Renal Failure Treatment Market Size, Share & Trends Analysis Report By Treatment (Dialysis, Kidney Transplantation, Drug Therapy), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Recreational Oxygen Equipment Market Growth & Trends
The global recreational oxygen equipment market size is expected to reach USD 11.5 billion by 2030, registering a CAGR of 15.2% during the forecast period, according to a new report by Grand View Research, Inc. High prevalence of unhealthy lifestyle among a large section of the global population has increased the risk of respiratory disorders such as chronic obstructive pulmonary disease (COPD). This is a major factor driving the need for recreational oxygen equipment. In addition, growing geriatric population, who is prone to numerous health disorders requiring supplemental oxygen, is expected to boost the market.
Consumer oxygen efficiently treats dementia and muscle recovery. Increase in awareness levels pertinent to the benefits of consumer O2 in the treatment of Obesity Hypoventilation Syndrome (OHS), COPD, dementia, and stress are projected to drive demand in the coming years. In 2015, the total population suffering from dementia was pegged at 47.47 million and is anticipated to rise to 75.63 million by over the next seven years. This represents lucrative opportunities for manufacturers in the field.
Recreational oxygen is also helpful during strenuous physical activities such as mountain climbing, where the altitude makes it difficult to breathe normally. Apart from this, these products have also been utilized in other recreational sports like skiing, hiking, biking, snowboarding, or floating at altitude. Owing to increasing popularity of these sports, demand for portable O2 devices for recreational use is on the rise. However, low awareness regarding the benefits of these devices in underdeveloped economies is hampering market growth. Key players in the market are focusing on creating awareness among consumers for medical as well as sports use, especially in untapped regions. This will help them establish a strong market presence over the course of the forecast period.
Companies are also investing in developing new, more effective, and innovative equipment to gain a foothold in the market. For instance, Sub Sea Systems installed the world's first underwater oxygen bar in Cozumel, Mexico in April 2015. This underwater attraction is designed to give customers the experience of being in a 13,000-gallon aquarium to play games and take pictures, all the while breathing in enriched O2.
Recreational Oxygen Equipment Market Report Highlights
Recreational Oxygen Equipment Market Growth & Trends
The global recreational oxygen equipment market size is expected to reach USD 11.5 billion by 2030, registering a CAGR of 15.2% during the forecast period, according to a new report by Grand View Research, Inc. High prevalence of unhealthy lifestyle among a large section of the global population has increased the risk of respiratory disorders such as chronic obstructive pulmonary disease (COPD). This is a major factor driving the need for recreational oxygen equipment. In addition, growing geriatric population, who is prone to numerous health disorders requiring supplemental oxygen, is expected to boost the market.
Consumer oxygen efficiently treats dementia and muscle recovery. Increase in awareness levels pertinent to the benefits of consumer O2 in the treatment of Obesity Hypoventilation Syndrome (OHS), COPD, dementia, and stress are projected to drive demand in the coming years. In 2015, the total population suffering from dementia was pegged at 47.47 million and is anticipated to rise to 75.63 million by over the next seven years. This represents lucrative opportunities for manufacturers in the field.
Recreational oxygen is also helpful during strenuous physical activities such as mountain climbing, where the altitude makes it difficult to breathe normally. Apart from this, these products have also been utilized in other recreational sports like skiing, hiking, biking, snowboarding, or floating at altitude. Owing to increasing popularity of these sports, demand for portable O2 devices for recreational use is on the rise. However, low awareness regarding the benefits of these devices in underdeveloped economies is hampering market growth. Key players in the market are focusing on creating awareness among consumers for medical as well as sports use, especially in untapped regions. This will help them establish a strong market presence over the course of the forecast period.
Companies are also investing in developing new, more effective, and innovative equipment to gain a foothold in the market. For instance, Sub Sea Systems installed the world's first underwater oxygen bar in Cozumel, Mexico in April 2015. This underwater attraction is designed to give customers the experience of being in a 13,000-gallon aquarium to play games and take pictures, all the while breathing in enriched O2.
Recreational Oxygen Equipment Market Report Highlights
- In 2023, the oxygen concentrators dominated the market and accounted for the largest revenue share of 40.9%.
- The athletics segment is expected to witness lucrative growth in the coming years. Professional athletes have been increasingly adopting this equipment owing to availability of portable and user-friendly products
- By application, the medical application dominated the market in 2023 and accounted for the largest revenue share of 39.2%.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Treatment Outlook
2.2.2. End Use Outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. RENAL FAILURE TREATMENT MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increased prevalence of CKD
3.2.1.2. Advancements in treatment technologies
3.2.1.3. Rising awareness and education about kidney health
3.2.1.4. Aging population
3.2.2. Market restraint analysis
3.2.2.1. High cost of treatment
3.2.2.2. Limited Healthcare Resources and Access
3.3. Renal Failure Treatment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. RENAL FAILURE TREATMENT MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Global Renal Failure Treatment Market: Treatment Dashboard
4.2. Global Renal Failure Treatment Market: Treatment Movement Analysis
4.3. Global Renal Failure Treatment Market by Treatments, Revenue
4.4. Dialysis
4.4.1. Dialysis market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Hemodialysis
4.4.2.1. Hemodialysis market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3. Peritoneal Dialysis
4.4.3.1. Peritoneal Dialysis market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Kidney Transplantation
4.5.1. Kidney transplantation market estimates and forecasts 2018 - 2030 (USD Million)
4.6. Drug Therapy
4.6.1. Drug therapy market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2. Antihypertensive Drugs
4.6.2.1. Antihypertensive Drugs market estimates and forecasts 2018 - 2030 (USD Million)
4.6.3. Antianemia Therapeutics (Erythropoiesis-Stimulating Agents)
4.6.3.1. Antianemia therapeutics (Erythropoiesis-Stimulating Agents) market estimates and forecasts 2018 - 2030 (USD Million)
4.6.4. Potassium Binders
4.6.4.1. Potassium Binders market estimates and forecasts 2018 - 2030 (USD Million)
4.6.5. Phosphate Binders
4.6.5.1. Phosphate Binders market estimates and forecasts 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. RENAL FAILURE TREATMENT MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Global Renal Failure Treatment Market: End Use Dashboard
5.2. Global Renal Failure Treatment Market: End Use Movement Analysis
5.3. Global Renal Failure Treatment Market Estimates and Forecasts, By End Use, Revenue (USD Million)
5.4. Hospitals
5.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Specialty Clinics
5.5.1. Specialty clinics market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. RENAL FAILURE TREATMENT MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY TREATMENT, AND END USE
6.1. Regional Dashboard
6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework/ reimbursement structure
6.3.1.3. Competitive scenario
6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
6.3.3. Mexico
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
6.4.3. France
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
6.4.4. Italy
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
6.4.5. Spain
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
6.4.6. Norway
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
6.5.3. India
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
6.5.4. Australia
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
6.6.2. Argentina
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
6.7.3. UAE
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
6.7.4. Kuwait
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Company/Competition Categorization
7.2. Vendor Landscape
7.2.1. List of key distributors and channel partners
7.2.2. Key company market share analysis, 2023
7.2.3. NIPRO
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Fresenius Medical Care AG
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Baxter
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Medtronic
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. B. Braun SE
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Asahi Kasei Medical Co., Ltd.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. AbbVie Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Nikkiso Co., Ltd.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. JMS Co., Ltd.
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. AstraZeneca
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Treatment Outlook
2.2.2. End Use Outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. RENAL FAILURE TREATMENT MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increased prevalence of CKD
3.2.1.2. Advancements in treatment technologies
3.2.1.3. Rising awareness and education about kidney health
3.2.1.4. Aging population
3.2.2. Market restraint analysis
3.2.2.1. High cost of treatment
3.2.2.2. Limited Healthcare Resources and Access
3.3. Renal Failure Treatment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. RENAL FAILURE TREATMENT MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Global Renal Failure Treatment Market: Treatment Dashboard
4.2. Global Renal Failure Treatment Market: Treatment Movement Analysis
4.3. Global Renal Failure Treatment Market by Treatments, Revenue
4.4. Dialysis
4.4.1. Dialysis market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Hemodialysis
4.4.2.1. Hemodialysis market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3. Peritoneal Dialysis
4.4.3.1. Peritoneal Dialysis market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Kidney Transplantation
4.5.1. Kidney transplantation market estimates and forecasts 2018 - 2030 (USD Million)
4.6. Drug Therapy
4.6.1. Drug therapy market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2. Antihypertensive Drugs
4.6.2.1. Antihypertensive Drugs market estimates and forecasts 2018 - 2030 (USD Million)
4.6.3. Antianemia Therapeutics (Erythropoiesis-Stimulating Agents)
4.6.3.1. Antianemia therapeutics (Erythropoiesis-Stimulating Agents) market estimates and forecasts 2018 - 2030 (USD Million)
4.6.4. Potassium Binders
4.6.4.1. Potassium Binders market estimates and forecasts 2018 - 2030 (USD Million)
4.6.5. Phosphate Binders
4.6.5.1. Phosphate Binders market estimates and forecasts 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. RENAL FAILURE TREATMENT MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Global Renal Failure Treatment Market: End Use Dashboard
5.2. Global Renal Failure Treatment Market: End Use Movement Analysis
5.3. Global Renal Failure Treatment Market Estimates and Forecasts, By End Use, Revenue (USD Million)
5.4. Hospitals
5.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Specialty Clinics
5.5.1. Specialty clinics market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. RENAL FAILURE TREATMENT MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY TREATMENT, AND END USE
6.1. Regional Dashboard
6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework/ reimbursement structure
6.3.1.3. Competitive scenario
6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
6.3.3. Mexico
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
6.4.3. France
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
6.4.4. Italy
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
6.4.5. Spain
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
6.4.6. Norway
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
6.5.3. India
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
6.5.4. Australia
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
6.6.2. Argentina
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
6.7.3. UAE
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
6.7.4. Kuwait
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Company/Competition Categorization
7.2. Vendor Landscape
7.2.1. List of key distributors and channel partners
7.2.2. Key company market share analysis, 2023
7.2.3. NIPRO
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Fresenius Medical Care AG
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Baxter
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Medtronic
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. B. Braun SE
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Asahi Kasei Medical Co., Ltd.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. AbbVie Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Nikkiso Co., Ltd.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. JMS Co., Ltd.
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. AstraZeneca
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
